NASDAQ:CMMB | Free Cash Flow | Chemomab Therapeutics Ltd.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2023-03-31-$7.19M$1,000.00-$7.19M
2022-12-31-$5.7M$1,000.00-$5.7M
2022-03-31-$3.71M$14,000.00-$3.73M
2021-12-31-$2.89M$134,000.00-$3.03M
2021-03-31-$1.29M$3,000.00-$1.3M
2020-12-31-$1.56M$1,000.00-$1.56M
2020-03-31-$1.91M$10,000.00-$1.92M
2019-12-31-$5.91M-$251,000.00-$6.17M
2019-03-31-$3.12M$75,000.00-$3.2M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$11.13M$3,000.00-$11.13M
2024-12-31-$15.39M$0.00-$15.39M
2023-12-31-$23.61M$3,000.00-$23.61M
2022-12-31-$20.37M$68,000.00-$20.44M
2021-12-31-$12.37M$239,000.00-$12.61M
2020-12-31-$5.24M$38,000.00-$5.28M
2019-12-31-$16.46M$95,000.00-$16.55M
2018-12-31-$14.22M$213,000.00-$14.44M